,SAMPLE_ID,biopsy_date,biopsy_year,birth_year,death_date,treatment_start_date,treatment,first_response_date,first_response_measure,last_response_date,last_response_measure,Recurrence_new_tumor_event,primary_tumor,metastatic_tumor,family_history_of_cancer,donor_age_at_diagnosis,platinum-based_chemotherapy,parpi_treatment,stable_disease_period_days,stable_disease_period_months,progression_free_survival_days,progression_free_survival_months,label
0,Sample_0001,2017-09-15,2017,1965,2017-11-17,2017-09-19,Doxorubicin,2017-10-13,PD,,,1.0,0,1,0,52,0,0.0,,,24.0,1.0,
1,Sample_0002,2017-10-31,2017,1975,,2017-11-07,Tamoxifen,2018-05-15,PD,,,1.0,0,1,0,42,0,0.0,,,189.0,6.0,
2,Sample_0003,2016-05-02,2016,1960,,2016-05-06,Carboplatin/Carboplatin/Paclitaxel/Paclitaxel,2016-07-01,PR,,,0.0,0,1,0,56,1,0.0,,,,,true_responder
3,Sample_0004,2016-06-15,2016,1948,2017-10-01,2016-06-16,Carboplatin/Doxorubicin,2016-09-05,SD,2017-01-13,PD,1.0,0,1,0,68,1,0.0,,,211.0,7.0,responder_based_on_PFS
4,Sample_0005,2016-10-05,2016,1950,2016-12-11,,,,,,,,0,1,0,66,use_as_blind_test,,,,,,other_use_as_test
5,Sample_0006,2016-12-13,2016,1947,2017-09-21,2016-12-14,Carboplatin/Paclitaxel/Pazopanib,2017-02-13,SD,2017-04-24,PD,1.0,0,1,0,69,1,0.0,,,131.0,4.0,nonresponder_based_on_PFS
6,Sample_0007,2016-12-29,2016,1946,2018-10-14,2017-01-11,Carboplatin/Doxorubicin/Paclitaxel,2017-03-13,SD,2017-06-07,PR,0.0,0,1,0,70,1,0.0,,,,,possible_reponder
7,Sample_0008,2017-02-13,2017,1957,,2017-03-13,Olaparib,2017-04-07,SD,,,0.0,0,1,1,60,0,1.0,25.0,1.0,,,
8,Sample_0009,2018-08-06,2018,1959,,2018-08-08,Carboplatin/Doxorubicin,2018-10-10,SD,2019-02-07,SD,0.0,0,1,0,59,1,0.0,183.0,6.0,,,responder_based_on_SD
9,Sample_0010,2017-05-04,2017,1976,2018-03-13,2017-05-04,Letrozole,2017-06-28,SD,2017-09-25,PD,1.0,0,1,0,41,0,0.0,,,144.0,5.0,
10,Sample_0011,2017-05-19,2017,1951,,2017-05-26,Carboplatin/Paclitaxel,2017-07-25,SD,2018-01-08,PD,1.0,0,1,0,66,1,0.0,,,227.0,7.0,responder_based_on_PFS
11,Sample_0012,2017-06-28,2017,1952,,2017-06-29,Carboplatin/Doxorubicin,2017-09-25,SD,,,0.0,0,1,0,65,1,0.0,88.0,3.0,,,nonresponder_based_on_SD
12,Sample_0013,2017-08-30,2017,1954,,2017-10-23,Carboplatin/Doxorubicin,2018-04-11,CR,2018-10-04,PD,1.0,1,0,0,63,1,0.0,,,346.0,11.0,true_responder
13,Sample_0014,2017-08-28,2017,1957,2018-08-23,2017-09-01,Carboplatin/Doxorubicin,2018-01-26,SD,,,0.0,0,1,0,60,1,0.0,147.0,5.0,,,nonresponder_based_on_SD
14,Sample_0015,2017-12-14,2017,1963,2019-06-07,2018-01-10,Bevacizumab/Paclitaxel/Carboplatin,2018-03-26,CR,2018-09-12,PD,1.0,0,1,0,54,1,0.0,,,245.0,8.0,true_responder
15,Sample_0016,2018-04-05,2018,1966,,2018-04-06,Carboplatin/Doxorubicin (liposomal)/Olaparib,2018-06-29,PR,2019-11-29,PD,1.0,0,1,0,52,1,1.0,,,602.0,20.0,true_responder
16,Sample_0017,2018-04-09,2018,1951,2019-02-19,2018-04-11,Carboplatin/Paclitaxel/Pazopanib,2018-06-11,SD,2018-09-03,PD,1.0,0,1,0,67,1,0.0,,,145.0,5.0,nonresponder_based_on_PFS
17,Sample_0018,2016-05-31,2016,1943,2016-10-25,2016-06-14,Bevacizumab/Carboplatin/Gemcitabine,2016-08-11,PD,,,1.0,0,1,0,73,1,0.0,,,58.0,2.0,true_nonresponder
18,Sample_0019,2016-07-18,2016,1956,,2016-07-20,Bevacizumab/Carboplatin/Gemcitabine,2016-09-28,PR,2017-06-08,PD,1.0,0,1,0,60,1,0.0,,,323.0,11.0,true_responder
19,Sample_0020,2016-10-10,2016,1954,,2016-10-12,Carboplatin/Gemcitabine/Niraparib/Olaparib,2017-02-13,PR,2019-07-16,CR,0.0,0,1,0,62,1,1.0,,,,,true_responder
20,Sample_0021,2016-10-10,2016,1950,2017-02-10,2016-10-13,Anastrozole,2016-12-28,PD,,,1.0,0,1,0,66,0,0.0,,,76.0,2.0,
21,Sample_0022,2016-11-25,2016,1954,,2016-12-15,Carboplatin/Paclitaxel,2017-01-18,PR,,,1.0,0,1,0,62,1,0.0,,,,,true_responder
22,Sample_0023,2016-11-30,2016,1958,2017-06-30,2016-12-06,Carboplatin,2017-03-20,PD,,,1.0,0,1,0,58,1,0.0,,,104.0,3.0,true_nonresponder
23,Sample_0024,2016-12-14,2016,1955,2019-01-12,2016-12-30,Carboplatin/Paclitaxel,2017-02-02,SD,,,0.0,0,1,0,61,1,0.0,34.0,1.0,,,nonresponder_based_on_SD
24,Sample_0025,2017-07-13,2017,1953,2019-10-22,2017-07-19,Paclitaxel/Carboplatin,2017-09-06,PR,,,0.0,0,1,0,64,1,0.0,,,,,true_responder
25,Sample_0026,2017-10-13,2017,1961,,2017-10-20,Carboplatin/Paclitaxel,2017-12-04,SD,2019-03-11,SD,0.0,1,0,0,56,1,0.0,507.0,17.0,,,responder_based_on_SD
26,Sample_0027,2017-12-04,2017,1946,2018-09-05,2017-12-05,Carboplatin/Gemcitabine,2018-02-07,PD,2018-04-24,PD,1.0,0,1,0,71,1,0.0,,,64.0,2.0,true_nonresponder
27,Sample_0028,2018-01-22,2018,1971,,2018-02-27,Bevacizumab/Gemcitabine,2018-05-15,SD,2018-07-04,PD,1.0,0,1,0,47,0,0.0,,,127.0,4.0,
28,Sample_0029,2018-03-21,2018,1975,,2018-04-05,Carboplatin/Paclitaxel,,,,,,0,1,0,43,1,0.0,,,,,other_use_as_test
29,Sample_0030,2018-04-03,2018,1947,2019-02-14,2018-04-03,Carboplatin/Niraparib/Paclitaxel,2018-07-24,PR,2019-01-02,PD,1.0,0,1,0,71,1,1.0,,,274.0,9.0,true_responder
30,Sample_0031,2018-04-24,2018,1942,,2018-05-01,Bevacizumab/Carboplatin/Gemcitabine,2018-07-05,CR,2019-04-04,PD,1.0,0,1,0,76,1,0.0,,,338.0,11.0,true_responder
31,Sample_0032,2018-04-26,2018,1949,2019-01-22,2018-05-17,Carboplatin/Paclitaxel,2018-06-14,SD,2018-12-06,SD,0.0,0,1,0,69,1,0.0,203.0,7.0,,,responder_based_on_SD
32,Sample_0033,2018-05-02,2018,1944,,2018-05-08,Carboplatin/Docetaxel,2018-07-03,SD,2019-01-22,PD,1.0,0,1,0,74,1,0.0,,,259.0,9.0,responder_based_on_PFS
33,Sample_0034,2018-05-16,2018,1962,,2018-05-22,Carboplatin/Gemcitabine/Niraparib,2018-10-02,PR,2019-04-17,PD,1.0,0,1,1,56,1,1.0,,,330.0,11.0,true_responder
34,Sample_0035,2018-05-29,2018,1953,,2018-06-07,Carboplatin/Docetaxel/Paclitaxel,2018-07-11,PR,,,0.0,0,1,0,65,1,0.0,,,,,true_responder
35,Sample_0036,2018-06-07,2018,1958,2018-07-23,2018-06-15,Doxorubicin (liposomal),,,,,,0,1,0,60,0,0.0,,,,,
36,Sample_0037,2016-08-31,2016,1956,2018-04-02,2016-09-05,Carboplatin/Gemcitabine,2016-11-14,PR,2017-01-20,PR,0.0,0,1,0,60,1,0.0,,,,,true_responder
37,Sample_0038,2016-10-18,2016,1952,2018-11-29,2016-10-22,Carboplatin/Paclitaxel,2016-11-28,SD,,,0.0,0,1,0,64,1,0.0,37.0,1.0,,,nonresponder_based_on_SD
38,Sample_0039,2017-03-28,2017,1944,,2017-04-10,Carboplatin/Paclitaxel,2017-05-16,PR,,,0.0,0,1,0,73,1,0.0,,,,,true_responder
39,Sample_0040,2017-07-04,2017,1948,,2017-07-25,Carboplatin/Paclitaxel,2017-08-25,SD,,,0.0,0,1,0,69,1,0.0,31.0,1.0,,,nonresponder_based_on_SD
40,Sample_0041,2017-08-15,2017,1956,,,,,,,,,0,1,0,61,use_as_blind_test,,,,,,other_use_as_test
41,Sample_0042,2017-08-22,2017,1943,2018-01-30,2017-09-11,Carboplatin/Paclitaxel,,,,,,0,1,0,74,1,0.0,,,,,other_use_as_test
42,Sample_0043,2017-11-07,2017,1953,,2017-11-16,Carboplatin/Paclitaxel,2017-12-19,PR,,,0.0,0,1,0,64,1,0.0,,,,,true_responder
43,Sample_0044,2018-02-01,2018,1941,,2018-02-13,Carboplatin/Paclitaxel,2018-03-13,PR,2018-07-18,SD,0.0,0,1,0,77,1,0.0,,,,,true_responder
44,Sample_0045,2018-02-01,2018,1950,,2018-02-05,Carboplatin/Paclitaxel,2018-03-12,SD,2018-10-18,SD,0.0,0,1,0,68,1,0.0,255.0,8.0,,,responder_based_on_SD
45,Sample_0046,2016-09-07,2016,1940,2017-01-24,2016-09-08,MSC2490484A,2016-10-18,PD,,,1.0,0,1,0,76,0,0.0,,,40.0,1.0,
46,Sample_0047,2017-07-13,2017,1941,2018-06-06,2017-08-02,Carboplatin/Doxorubicin,2018-01-23,PR,2018-04-24,PD,1.0,0,1,0,76,1,0.0,,,265.0,9.0,true_responder
47,Sample_0048,2018-04-24,2018,1961,,,,,,,,,0,1,0,57,use_as_blind_test,,,,,,other_use_as_test
48,Sample_0049,2016-11-29,2016,1960,2018-11-13,2016-12-05,Letrozole,2017-04-07,SD,,,0.0,0,1,0,56,0,0.0,123.0,4.0,,,
49,Sample_0050,2016-12-07,2016,1954,,,,,,,,,0,1,0,62,use_as_blind_test,,,,,,other_use_as_test
50,Sample_0051,2017-04-12,2017,1965,2018-09-11,,,,,,,,0,1,0,52,use_as_blind_test,,,,,,other_use_as_test
51,Sample_0052,2017-04-19,2017,1967,,2017-06-21,Bevacizumab/Carboplatin/Gemcitabine,2017-08-29,PR,2017-11-06,PR,0.0,0,1,0,50,1,0.0,,,,,true_responder
52,Sample_0053,2017-05-19,2017,1956,,2017-08-01,Carboplatin/Paclitaxel,2017-10-20,SD,2018-02-28,SD,0.0,0,1,0,61,1,0.0,211.0,7.0,,,responder_based_on_SD
53,Sample_0054,2017-06-30,2017,1962,,2017-09-07,Carboplatin/Paclitaxel,2017-09-08,SD,2018-01-17,PR,0.0,0,1,0,55,1,0.0,,,,,possible_reponder
54,Sample_0055,2017-07-05,2017,1972,,2017-07-17,Tamoxifen,,,,,,0,1,0,45,0,0.0,,,,,
55,Sample_0056,2017-08-17,2017,1970,2017-10-01,,,,,,,0.0,0,1,0,47,use_as_blind_test,,,,,,other_use_as_test
56,Sample_0057,2017-09-22,2017,1973,,2017-10-03,Carboplatin/Doxorubicin (liposomal)/Mutant p53 reactivating compound APR-246 (PRIMA-1Met),2017-11-24,SD,2018-05-23,PD,1.0,0,1,0,44,1,0.0,,,232.0,8.0,responder_based_on_PFS
57,Sample_0058,2017-12-21,2017,1953,,,,,,,,,0,1,0,64,use_as_blind_test,,,,,,other_use_as_test
58,Sample_0059,2018-01-10,2018,1945,,2018-02-06,Cisplatin,,,,,,0,1,0,73,1,0.0,,,,,other_use_as_test
59,Sample_0060,2018-02-18,2018,1952,,,,,,,,,1,0,0,66,use_as_blind_test,,,,,,other_use_as_test
60,Sample_0061,2018-12-19,2018,1970,,,,,,,,,0,1,0,48,use_as_blind_test,,,,,,other_use_as_test
61,Sample_0062,2016-12-27,2016,1955,2018-08-01,2017-03-14,Paclitaxel/Carboplatin,2017-05-31,PR,2018-01-17,PD,1.0,0,1,0,61,1,0.0,,,309.0,10.0,true_responder
62,Sample_0063,2017-07-27,2017,1948,2017-09-21,2017-07-31,Topotecan,,,,,,0,1,0,69,0,0.0,,,,,
63,Sample_0064,2017-08-28,2017,1979,2017-12-28,,,,,,,,0,1,0,38,use_as_blind_test,,,,,,other_use_as_test
64,Sample_0065,2017-09-21,2017,1949,,,,,,,,,0,1,0,68,use_as_blind_test,,,,,,other_use_as_test
65,Sample_0066,2017-12-14,2017,1956,,2018-01-19,Bevacizumab/Carboplatin/Paclitaxel,2018-03-15,SD,2019-10-22,CR,0.0,0,1,0,61,1,0.0,,,,,possible_reponder
66,Sample_0067,2018-05-03,2018,1946,2018-07-30,2018-05-08,Atezolizumab/Bevacizumab,2018-07-03,PD,,,1.0,0,1,0,72,0,0.0,,,56.0,2.0,
67,Sample_0068,2018-05-02,2018,1981,,,,,,,,,0,1,0,37,use_as_blind_test,,,,,,other_use_as_test
68,Sample_0069,2018-05-22,2018,1940,2018-09-10,2018-05-28,Atezolizumab/Bevacizumab,2018-07-26,SD,,,0.0,0,1,0,78,0,0.0,59.0,2.0,,,
69,Sample_0070,2018-09-27,2018,1965,2019-09-18,2018-10-02,Atezolizumab/Bevacizumab,,,,,,0,1,0,53,0,0.0,,,,,
70,Sample_0071,2018-12-18,2018,1958,,2018-12-20,Atezolizumab/Bevacizumab,2019-02-11,PD,,,1.0,0,1,0,60,0,0.0,,,53.0,2.0,
71,Sample_0072,2019-01-11,2018,1955,,2019-01-28,Bevacizumab,2019-03-15,PR,2019-05-27,PD,1.0,0,1,0,63,0,0.0,,,119.0,4.0,
72,Sample_0073,2019-04-16,2018,1953,,,,,,,,,0,1,0,65,use_as_blind_test,,,,,,other_use_as_test
73,Sample_0074,2016-07-06,2016,1950,,2016-07-07,Carboplatin/Doxorubicin,2016-09-15,SD,2016-12-15,SD,0.0,0,1,0,66,1,0.0,161.0,5.0,,,nonresponder_based_on_SD
74,Sample_0075,2017-04-05,2017,1978,2017-11-08,2017-05-31,Trametinib,2017-08-25,SD,2017-10-12,SD,0.0,0,1,0,39,0,0.0,134.0,4.0,,,
75,Sample_0076,2017-10-27,2017,1951,,,,,,,,,0,1,0,66,use_as_blind_test,,,,,,other_use_as_test
76,Sample_0077,2018-01-17,2018,1940,,2018-01-25,Carboplatin/Doxorubicin (liposomal)/Doxorubicin (liposomal),,,,,,0,1,0,78,1,0.0,,,,,other_use_as_test
77,Sample_0078,2018-02-01,2018,1986,2018-04-30,,,,,,,,0,1,0,32,use_as_blind_test,,,,,,other_use_as_test
78,Sample_0079,2018-05-08,2018,1942,,2018-07-10,Bevacizumab/Durvalumab/Olaparib,2018-08-29,SD,,,0.0,0,1,0,76,0,1.0,50.0,2.0,,,
79,Sample_0080,2017-06-20,2017,1947,2017-12-22,2017-06-23,Carboplatin/Paclitaxel,,,,,,0,1,0,70,1,0.0,,,,,other_use_as_test
80,Sample_0081,2017-07-04,2017,1953,,2017-07-05,Tamoxifen,2017-09-25,SD,2018-04-09,PD,1.0,0,1,0,64,0,0.0,,,278.0,9.0,
81,Sample_0082,2017-07-31,2017,1986,2018-07-20,2017-08-10,Tim-3 blocker,2017-09-29,PD,2018-01-02,PD,1.0,0,1,0,31,0,0.0,,,50.0,2.0,
82,Sample_0083,2018-02-20,2018,1956,,2018-02-21,Carboplatin/Doxorubicin (liposomal),2018-05-04,PD,,,1.0,0,1,0,62,1,0.0,,,72.0,2.0,true_nonresponder
83,Sample_0084,2016-09-09,2016,1952,,,,,,,,,0,1,0,64,use_as_blind_test,,,,,,other_use_as_test
84,Sample_0085,2017-09-25,2017,1940,,2017-10-10,Bevacizumab/Carboplatin/Gemcitabine,2017-12-14,PR,2019-05-11,PD,1.0,0,1,0,77,1,0.0,,,578.0,19.0,true_responder
85,Sample_0086,2017-10-12,2017,1942,,2017-10-26,Bevacizumab/Carboplatin/Gemcitabine,2017-12-18,PR,2019-06-21,PR,0.0,0,1,0,75,1,0.0,,,,,true_responder
86,Sample_0087,2018-02-01,2018,1942,,2018-02-13,Bevacizumab/Carboplatin/Gemcitabine,2018-04-04,CR,2019-06-07,PD,1.0,0,1,0,76,1,0.0,,,479.0,16.0,true_responder
87,Sample_0088,2017-02-16,2017,1958,2018-08-21,2017-03-10,Carboplatin/Paclitaxel,2017-04-14,PR,2017-10-10,PD,1.0,0,1,0,59,1,0.0,,,214.0,7.0,true_responder
88,Sample_0089,2018-06-06,2018,1967,2019-03-03,2018-06-14,Bevacizumab/Doxorubicin (liposomal)/Carboplatin,2018-07-30,PD,,,1.0,0,1,0,51,1,0.0,,,46.0,2.0,true_nonresponder
89,Sample_0090,2018-06-29,2018,1956,2019-03-04,2018-07-10,Carboplatin/Paclitaxel,2018-09-12,SD,2018-12-12,SD,0.0,0,1,0,62,1,0.0,155.0,5.0,,,nonresponder_based_on_SD
90,Sample_0091,2017-06-02,2017,1939,,2017-06-08,Bevacizumab/Carboplatin/Gemcitabine,2017-08-10,PR,2018-02-27,PD,1.0,0,1,0,78,1,0.0,,,264.0,9.0,true_responder
91,Sample_0092,2017-06-13,2017,1960,2018-04-28,2017-06-16,Bevacizumab/Carboplatin/Gemcitabine,2017-08-07,PR,2017-11-29,PD,1.0,0,1,0,57,1,0.0,,,166.0,5.0,true_responder
92,Sample_0093,2018-03-13,2018,1974,2019-07-26,2018-04-17,Bevacizumab/Carboplatin/Gemcitabine,2018-06-12,SD,2019-01-14,PD,1.0,0,1,0,44,1,0.0,,,272.0,9.0,responder_based_on_PFS
93,Sample_0094,2018-02-27,2018,1981,2018-12-07,2018-03-01,Carboplatin/Paclitaxel,2018-04-30,PR,2018-07-12,PD,1.0,0,1,0,37,1,0.0,,,133.0,4.0,true_responder
94,Sample_0095,2018-04-17,2018,1955,2018-07-30,2018-04-20,Bevacizumab/Carboplatin/Gemcitabine,2018-06-18,SD,,,0.0,0,1,0,63,1,0.0,59.0,2.0,,,nonresponder_based_on_SD
95,Sample_0096,2018-05-22,2018,1940,,,,,,,,,0,1,0,78,use_as_blind_test,,,,,,other_use_as_test
96,Sample_0097,2018-05-31,2018,1948,,2018-06-12,Bevacizumab/Carboplatin/Gemcitabine,2018-08-14,SD,2019-09-10,SD,0.0,0,1,0,70,1,0.0,455.0,15.0,,,responder_based_on_SD
97,Sample_0098,2018-02-23,2018,1963,2018-04-19,2018-02-23,Paclitaxel,,,,,,0,1,0,55,0,0.0,,,,,
98,Sample_0099,2018-02-27,2018,1957,2018-08-28,2018-03-02,Carboplatin,2018-05-16,PD,,,1.0,0,1,0,61,1,0.0,,,75.0,2.0,true_nonresponder
99,Sample_0100,2018-03-22,2018,1946,2018-05-21,2018-03-23,Carboplatin/Gemcitabine,2018-05-08,PD,,,1.0,0,1,0,72,1,0.0,,,46.0,2.0,true_nonresponder
100,Sample_0101,2018-03-23,2018,1942,,2018-03-28,Carboplatin/Gemcitabine,2018-05-25,SD,2018-08-08,SD,0.0,0,1,0,76,1,0.0,133.0,4.0,,,nonresponder_based_on_SD
101,Sample_0102,2018-03-28,2018,1972,,,,,,,,,0,1,0,46,use_as_blind_test,,,,,,other_use_as_test
102,Sample_0103,2018-05-29,2018,1969,2019-04-23,2018-06-01,Carboplatin/Doxorubicin,2018-08-08,SD,2018-08-08,SD,,0,1,0,49,1,0.0,68.0,2.0,,,nonresponder_based_on_SD
103,Sample_0104,2017-01-18,2017,1932,2017-03-15,,,,,,,,0,1,0,85,use_as_blind_test,,,,,,other_use_as_test
104,Sample_0105,2017-11-06,2017,1947,2019-01-15,2017-11-09,Carboplatin/Doxorubicin (liposomal),2018-05-02,PR,,,0.0,0,1,0,70,1,0.0,,,,,true_responder
105,Sample_0106,2016-11-23,2016,1954,,2016-11-25,Doxorubicin/Cisplatin,2017-02-13,PR,2017-05-22,PD,1.0,0,1,0,62,1,0.0,,,178.0,6.0,true_responder
106,Sample_0107,2017-05-08,2017,1938,,2017-05-29,Carboplatin/Gemcitabine,2017-07-27,SD,2017-09-22,SD,0.0,0,1,0,79,1,0.0,116.0,4.0,,,nonresponder_based_on_SD
107,Sample_0108,2017-12-12,2017,1958,2019-09-11,2018-01-05,Carboplatin/Paclitaxel,2018-02-12,PR,,,0.0,0,1,0,59,1,0.0,,,,,true_responder
108,Sample_0109,2016-10-19,2016,1944,,2016-10-28,Carboplatin/Paclitaxel,2017-03-13,PR,2017-12-04,PD,1.0,0,1,0,72,1,0.0,,,402.0,13.0,true_responder
109,Sample_0110,2018-02-28,2018,1962,,2018-03-06,Bevacizumab/Paclitaxel/Carboplatin,2018-06-04,SD,2018-07-02,PD,1.0,0,1,0,56,1,0.0,,,118.0,4.0,nonresponder_based_on_PFS
110,Sample_0111,2018-06-20,2018,1947,,2018-07-17,Carboplatin,2018-09-19,SD,2019-01-04,SD,0.0,0,1,0,71,1,0.0,171.0,6.0,,,responder_based_on_SD
111,Sample_0112,2018-06-01,2018,1967,,2018-06-05,Carboplatin,2018-10-08,PR,,,0.0,0,1,0,51,1,0.0,,,,,true_responder
112,Sample_0113,2017-01-04,2017,1955,2017-01-14,,,,,,,,0,1,0,62,use_as_blind_test,,,,,,other_use_as_test
113,Sample_0114,2018-03-12,2018,1944,,2018-04-03,Carboplatin/Paclitaxel,2018-05-29,PR,,,0.0,0,1,0,74,1,0.0,,,,,true_responder
114,Sample_0115,2019-05-13,2018,1953,2019-08-09,2019-05-24,Gemcitabine/Carboplatin,2019-05-29,SD,,,0.0,0,1,0,65,1,0.0,5.0,0.0,,,nonresponder_based_on_SD
115,Sample_0116,2017-09-14,2017,1947,2018-03-06,2017-10-02,Carboplatin,2017-11-27,SD,,,0.0,0,1,0,70,1,0.0,56.0,2.0,,,nonresponder_based_on_SD
116,Sample_0117,2018-01-16,2018,1945,2019-08-18,2018-01-30,Carboplatin,2018-06-05,SD,2018-11-13,PD,1.0,0,1,0,73,1,0.0,,,287.0,9.0,responder_based_on_PFS
117,Sample_0118,2018-04-30,2018,1951,2019-06-04,2018-05-03,Bevacizumab/Carboplatin/Gemcitabine,2018-06-27,PR,2018-09-12,PR,0.0,1,0,0,67,1,0.0,,,,,true_responder
118,Sample_0119,2018-02-13,2018,1951,2019-06-17,2018-02-16,Carboplatin,2018-05-07,SD,2019-01-09,PD,1.0,0,1,0,67,1,0.0,,,327.0,11.0,responder_based_on_PFS
119,Sample_0120,2018-04-06,2018,1944,2018-12-23,2018-04-23,Bevacizumab/Doxorubicin/Carboplatin,2018-06-12,SD,2018-10-02,PD,1.0,0,1,0,74,1,0.0,,,162.0,5.0,nonresponder_based_on_PFS
120,Sample_0121,2017-10-18,2017,1951,2017-10-30,2017-10-21,Anastrozole,,,,,,0,1,0,66,0,0.0,,,,,
121,Sample_0122,2018-01-12,2018,1965,,2018-01-22,Bevacizumab/Carboplatin/Gemcitabine,2018-04-16,SD,2018-08-14,SD,0.0,1,0,0,53,1,0.0,204.0,7.0,,,responder_based_on_SD
122,Sample_0123,2017-11-10,2017,1955,,2017-11-22,Doxorubicin/Carboplatin,2018-02-09,PD,,,1.0,0,1,0,62,1,0.0,,,79.0,3.0,true_nonresponder
123,Sample_0124,2018-06-14,2018,1948,2018-10-09,2018-07-23,Capecitabine/Oxaliplatin,2018-09-19,PD,,,1.0,0,1,0,70,1,0.0,,,58.0,2.0,true_nonresponder
124,Sample_0125,2017-03-08,2017,1964,,2017-03-16,Carboplatin/Paclitaxel,2017-04-19,SD,2017-06-23,PD,1.0,0,1,0,53,1,0.0,,,99.0,3.0,nonresponder_based_on_PFS
125,Sample_0126,2017-03-22,2017,1950,,2017-04-10,Carboplatin/Letrozole/Paclitaxel,2017-06-06,SD,2017-09-25,PD,1.0,0,1,0,67,1,0.0,,,168.0,6.0,responder_based_on_PFS
126,Sample_0127,2018-01-12,2018,1944,,2018-02-02,Topotecan,2018-03-22,SD,2018-08-06,PD,1.0,0,1,0,74,0,0.0,,,185.0,6.0,
127,Sample_0128,2017-10-17,2017,1954,,2017-10-19,Bevacizumab/Carboplatin/Gemcitabine,2017-12-21,SD,2018-08-14,SD,0.0,0,1,0,63,1,0.0,299.0,10.0,,,responder_based_on_SD
128,Sample_0129,2017-11-14,2017,1942,2017-11-30,2017-11-20,Cabazitaxel/Paclitaxel,,,,,,0,1,0,75,0,0.0,,,,,
129,Sample_0130,2018-03-01,2018,1960,2018-12-03,2018-03-06,Doxorubicin (liposomal),,,,,,0,1,0,58,0,0.0,,,,,
130,Sample_0131,2018-01-15,2018,1963,2018-10-05,2018-01-23,Bevacizumab/Carboplatin/Paclitaxel,2018-03-21,PR,2018-09-24,PD,1.0,0,1,0,55,1,0.0,,,244.0,8.0,true_responder
131,Sample_0132,2018-04-04,2018,1948,,2018-04-24,Tamoxifen,2019-02-27,PD,,,1.0,0,1,0,70,0,0.0,,,309.0,10.0,
132,Sample_0133,2018-06-11,2018,1958,,2018-06-15,Carboplatin/Paclitaxel,2018-08-13,SD,2018-10-29,SD,0.0,0,1,0,60,1,0.0,136.0,4.0,,,nonresponder_based_on_SD
133,Sample_0134,2017-11-21,2017,1964,,2017-11-22,Carboplatin/Paclitaxel,2017-12-21,SD,,,0.0,0,1,0,53,1,0.0,29.0,1.0,,,nonresponder_based_on_SD
